Design and evaluations of a phased ultrasound array for transesophageal cardiac ablation

Devina Jaiswal, Jacob Robert Werner, Eun Joo Park, Nadine Barrie Smith, David Francischelli

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Atrial fibrillation is one of the most common arrhythmia, affecting over 2.2 million Americans. A prevailing modality for treating paroxysmal atrial fibrillation is catheter ablation using radiofrequency. However, measurable morbidity and significant costs and time are associated with this modality of treatment of permanent or persistent atrial fibrillation. In order to overcome these issues, a transesophageal ultrasound applicator for noninvasive cardiac ablation was designed, developed and evaluated. Various factors, simulation results of transducer arrays, current transesophageal medical devices, and throat anatomy, were considered while designing a phased ultrasound transducer that can be inserted into the esophagus. For this research, a two-dimensional random sparse phased array with an aperture size of 20.7mm x 10.2mm with flat tapered elements as a transesophageal ultrasound applicator was fabricated and evaluated in ex vivo experiments. The ultrasound applicator was designed to operate at a frequency of 1.6 MHz. The feasibility of the sparse phased array was tested by submerging the array and the fresh tissue into phosphate buffer saline (PBS) solution and directing the ultrasound directly onto the tissue. Both the bovine liver and porcine heart developed lesion at the target site as a result of 8 ∼15 minutes of array operation. The lesion had an average length of 7 ± 2 mm and a width of 5 ± 2 mm. Experimental results indicate that sufficient power was delivered by the array at the focal point to produce ablation while not grossly damaging the tissue surrounding the area of interest. These results demonstrate a potential application of the ultrasound applicator for noninvasive transesophageal cardiac surgery in atrial fibrillation treatment.

Original languageEnglish (US)
Title of host publication2009 IEEE International Ultrasonics Symposium and Short Courses, IUS 2009
DOIs
StatePublished - Dec 1 2009
Event2009 IEEE International Ultrasonics Symposium, IUS 2009 - Rome, Italy
Duration: Sep 20 2009Sep 23 2009

Publication series

NameProceedings - IEEE Ultrasonics Symposium
ISSN (Print)1051-0117

Other

Other2009 IEEE International Ultrasonics Symposium, IUS 2009
CountryItaly
CityRome
Period9/20/099/23/09

Fingerprint

fibrillation
phased arrays
ablation
evaluation
lesions
transducers
arrhythmia
esophagus
throats
anatomy
liver
surgery
submerging
phosphates
buffers
apertures
costs
simulation

All Science Journal Classification (ASJC) codes

  • Acoustics and Ultrasonics

Cite this

Jaiswal, D., Werner, J. R., Park, E. J., Smith, N. B., & Francischelli, D. (2009). Design and evaluations of a phased ultrasound array for transesophageal cardiac ablation. In 2009 IEEE International Ultrasonics Symposium and Short Courses, IUS 2009 [5441839] (Proceedings - IEEE Ultrasonics Symposium). https://doi.org/10.1109/ULTSYM.2009.5441839
Jaiswal, Devina ; Werner, Jacob Robert ; Park, Eun Joo ; Smith, Nadine Barrie ; Francischelli, David. / Design and evaluations of a phased ultrasound array for transesophageal cardiac ablation. 2009 IEEE International Ultrasonics Symposium and Short Courses, IUS 2009. 2009. (Proceedings - IEEE Ultrasonics Symposium).
@inproceedings{37028eb6b7534c2f8523f2ed21adfd5f,
title = "Design and evaluations of a phased ultrasound array for transesophageal cardiac ablation",
abstract = "Atrial fibrillation is one of the most common arrhythmia, affecting over 2.2 million Americans. A prevailing modality for treating paroxysmal atrial fibrillation is catheter ablation using radiofrequency. However, measurable morbidity and significant costs and time are associated with this modality of treatment of permanent or persistent atrial fibrillation. In order to overcome these issues, a transesophageal ultrasound applicator for noninvasive cardiac ablation was designed, developed and evaluated. Various factors, simulation results of transducer arrays, current transesophageal medical devices, and throat anatomy, were considered while designing a phased ultrasound transducer that can be inserted into the esophagus. For this research, a two-dimensional random sparse phased array with an aperture size of 20.7mm x 10.2mm with flat tapered elements as a transesophageal ultrasound applicator was fabricated and evaluated in ex vivo experiments. The ultrasound applicator was designed to operate at a frequency of 1.6 MHz. The feasibility of the sparse phased array was tested by submerging the array and the fresh tissue into phosphate buffer saline (PBS) solution and directing the ultrasound directly onto the tissue. Both the bovine liver and porcine heart developed lesion at the target site as a result of 8 ∼15 minutes of array operation. The lesion had an average length of 7 ± 2 mm and a width of 5 ± 2 mm. Experimental results indicate that sufficient power was delivered by the array at the focal point to produce ablation while not grossly damaging the tissue surrounding the area of interest. These results demonstrate a potential application of the ultrasound applicator for noninvasive transesophageal cardiac surgery in atrial fibrillation treatment.",
author = "Devina Jaiswal and Werner, {Jacob Robert} and Park, {Eun Joo} and Smith, {Nadine Barrie} and David Francischelli",
year = "2009",
month = "12",
day = "1",
doi = "10.1109/ULTSYM.2009.5441839",
language = "English (US)",
isbn = "9781424443895",
series = "Proceedings - IEEE Ultrasonics Symposium",
booktitle = "2009 IEEE International Ultrasonics Symposium and Short Courses, IUS 2009",

}

Jaiswal, D, Werner, JR, Park, EJ, Smith, NB & Francischelli, D 2009, Design and evaluations of a phased ultrasound array for transesophageal cardiac ablation. in 2009 IEEE International Ultrasonics Symposium and Short Courses, IUS 2009., 5441839, Proceedings - IEEE Ultrasonics Symposium, 2009 IEEE International Ultrasonics Symposium, IUS 2009, Rome, Italy, 9/20/09. https://doi.org/10.1109/ULTSYM.2009.5441839

Design and evaluations of a phased ultrasound array for transesophageal cardiac ablation. / Jaiswal, Devina; Werner, Jacob Robert; Park, Eun Joo; Smith, Nadine Barrie; Francischelli, David.

2009 IEEE International Ultrasonics Symposium and Short Courses, IUS 2009. 2009. 5441839 (Proceedings - IEEE Ultrasonics Symposium).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - Design and evaluations of a phased ultrasound array for transesophageal cardiac ablation

AU - Jaiswal, Devina

AU - Werner, Jacob Robert

AU - Park, Eun Joo

AU - Smith, Nadine Barrie

AU - Francischelli, David

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Atrial fibrillation is one of the most common arrhythmia, affecting over 2.2 million Americans. A prevailing modality for treating paroxysmal atrial fibrillation is catheter ablation using radiofrequency. However, measurable morbidity and significant costs and time are associated with this modality of treatment of permanent or persistent atrial fibrillation. In order to overcome these issues, a transesophageal ultrasound applicator for noninvasive cardiac ablation was designed, developed and evaluated. Various factors, simulation results of transducer arrays, current transesophageal medical devices, and throat anatomy, were considered while designing a phased ultrasound transducer that can be inserted into the esophagus. For this research, a two-dimensional random sparse phased array with an aperture size of 20.7mm x 10.2mm with flat tapered elements as a transesophageal ultrasound applicator was fabricated and evaluated in ex vivo experiments. The ultrasound applicator was designed to operate at a frequency of 1.6 MHz. The feasibility of the sparse phased array was tested by submerging the array and the fresh tissue into phosphate buffer saline (PBS) solution and directing the ultrasound directly onto the tissue. Both the bovine liver and porcine heart developed lesion at the target site as a result of 8 ∼15 minutes of array operation. The lesion had an average length of 7 ± 2 mm and a width of 5 ± 2 mm. Experimental results indicate that sufficient power was delivered by the array at the focal point to produce ablation while not grossly damaging the tissue surrounding the area of interest. These results demonstrate a potential application of the ultrasound applicator for noninvasive transesophageal cardiac surgery in atrial fibrillation treatment.

AB - Atrial fibrillation is one of the most common arrhythmia, affecting over 2.2 million Americans. A prevailing modality for treating paroxysmal atrial fibrillation is catheter ablation using radiofrequency. However, measurable morbidity and significant costs and time are associated with this modality of treatment of permanent or persistent atrial fibrillation. In order to overcome these issues, a transesophageal ultrasound applicator for noninvasive cardiac ablation was designed, developed and evaluated. Various factors, simulation results of transducer arrays, current transesophageal medical devices, and throat anatomy, were considered while designing a phased ultrasound transducer that can be inserted into the esophagus. For this research, a two-dimensional random sparse phased array with an aperture size of 20.7mm x 10.2mm with flat tapered elements as a transesophageal ultrasound applicator was fabricated and evaluated in ex vivo experiments. The ultrasound applicator was designed to operate at a frequency of 1.6 MHz. The feasibility of the sparse phased array was tested by submerging the array and the fresh tissue into phosphate buffer saline (PBS) solution and directing the ultrasound directly onto the tissue. Both the bovine liver and porcine heart developed lesion at the target site as a result of 8 ∼15 minutes of array operation. The lesion had an average length of 7 ± 2 mm and a width of 5 ± 2 mm. Experimental results indicate that sufficient power was delivered by the array at the focal point to produce ablation while not grossly damaging the tissue surrounding the area of interest. These results demonstrate a potential application of the ultrasound applicator for noninvasive transesophageal cardiac surgery in atrial fibrillation treatment.

UR - http://www.scopus.com/inward/record.url?scp=77952794640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952794640&partnerID=8YFLogxK

U2 - 10.1109/ULTSYM.2009.5441839

DO - 10.1109/ULTSYM.2009.5441839

M3 - Conference contribution

AN - SCOPUS:77952794640

SN - 9781424443895

T3 - Proceedings - IEEE Ultrasonics Symposium

BT - 2009 IEEE International Ultrasonics Symposium and Short Courses, IUS 2009

ER -

Jaiswal D, Werner JR, Park EJ, Smith NB, Francischelli D. Design and evaluations of a phased ultrasound array for transesophageal cardiac ablation. In 2009 IEEE International Ultrasonics Symposium and Short Courses, IUS 2009. 2009. 5441839. (Proceedings - IEEE Ultrasonics Symposium). https://doi.org/10.1109/ULTSYM.2009.5441839